For men diagnosed with locally advanced prostate cancer, a novel treatment option is showing promise. A recent clinical trial has demonstrated that hormone patches are as effective as traditional injections in suppressing testosterone, a key factor in slowing cancer growth. This finding could offer a more convenient and potentially better-tolerated approach for many patients facing this diagnosis.
Prostate cancer is the most common cancer in American men, aside from skin cancer, with an estimated 299,010 new cases expected in 2024, according to the American Cancer Society . Locally advanced prostate cancer, meaning the cancer has spread beyond the prostate gland but not to distant parts of the body, often requires androgen deprivation therapy (ADT) to lower testosterone levels. Traditionally, this has involved regular injections or implants.
The study, published in The Lancet Oncology, focused on the use of a transdermal testosterone patch – essentially a skin patch that delivers a steady dose of the hormone – compared to standard injectable ADT. Researchers found that both methods were equally effective in reducing testosterone to the desired levels. The trial involved 319 patients with locally advanced prostate cancer who were randomly assigned to receive either the patch or the injections. The primary endpoint was achieving and maintaining castrate levels of testosterone, which is considered crucial for controlling the cancer’s progression.
Hormone Patches Offer Convenience and Potential Benefits
The key advantage of the hormone patch lies in its convenience. Instead of requiring regular visits to a doctor’s office for injections, patients can self-apply the patch at home. This can significantly reduce the burden of treatment and improve adherence. “For many men, the idea of avoiding regular injections is very appealing,” explains Dr. Neal Shore, a medical oncologist at Cleveland Clinic and a lead investigator in the study. “It simplifies the treatment process and gives patients more control over their care.”
Beyond convenience, the patch may as well offer a more favorable side effect profile. Even as both methods can cause side effects such as fatigue, hot flashes, and decreased libido, some patients may experience fewer fluctuations in hormone levels with the patch, potentially leading to more consistent symptom management. However, the study did not specifically focus on comparing side effects, and further research is needed to confirm this potential benefit.
How the Clinical Trial Was Conducted
The phase 3 clinical trial, known as the PATCH trial, was conducted at multiple centers across Europe and North America. Participants were monitored closely for testosterone levels and any adverse events. The study lasted for approximately 18 months, with researchers assessing the percentage of patients who maintained castrate levels of testosterone throughout the treatment period. The results showed no statistically significant difference between the patch and injection groups in terms of testosterone suppression.
Researchers also evaluated the safety of the patch, finding that it was generally well-tolerated. The most common side effects were skin reactions at the application site, which were typically mild and manageable. Serious adverse events were rare and occurred at similar rates in both groups.
Implications for Prostate Cancer Treatment
The findings from this trial could lead to a shift in how locally advanced prostate cancer is treated. While injections remain a standard option, the hormone patch now provides a viable alternative for men who prefer a more convenient and self-administered approach. The availability of this new option could also improve treatment adherence, which is crucial for achieving optimal outcomes.
However, it’s key to note that the patch may not be suitable for all patients. Factors such as skin sensitivity and the ability to self-apply the patch will necessitate to be considered. A thorough discussion with a healthcare provider is essential to determine the best treatment option for each individual.
What’s Next for Hormone Patch Therapy?
Researchers are continuing to investigate the long-term effects of hormone patch therapy and its potential impact on quality of life. Future studies will also explore whether the patch can be used in combination with other treatments, such as chemotherapy or radiation therapy. The ultimate goal is to develop more effective and personalized treatment strategies for men with prostate cancer.
The U.S. Food and Drug Administration (FDA) is currently reviewing the data from the PATCH trial to determine whether to approve the hormone patch for use in the United States. A decision is expected in the coming months. Once approved, the patch will become another valuable tool in the fight against prostate cancer, offering patients more choices and control over their treatment journey.
Disclaimer: This article is for informational purposes only and should not be considered medical advice. Please consult with a qualified healthcare professional for any health concerns or before making any decisions related to your treatment.
Have you or a loved one been affected by prostate cancer? Share your thoughts and experiences in the comments below. And please, share this article with anyone who might find it helpful.
Related reading
- Monash, Synchrotron Launch $2.9M HTX System for Accelerated Drug Development
- Ultrasound-Guided Fascia Iliaca Blocks Reduce Opioid Use in Hip Surgery
- Father of Slain Children Testifies in Ex-Wife’s Murder Trial Highlighting Mental Health Decline (archyde.com)
- J&J Offers $5.5bn to Settle Talc Cancer Lawsuits (newsy-today.com)
